Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo

Amyloid

Volumn 11, Issue 2, 2004, Pages 113-120

  Wei, Lan ^a   Kawano, Hiroo ^b   Fu, Xiaoying ^c   Cui, Dan ^b   Ito, Sadahiro ^a   Yamamura, Ken Ichi ^d   Ishihara, Tokuhiro ^b   Tokuda, Takahiko ^e   Higuchi, Keiichi ^c   Maeda, Shuichiro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyloid; Amyloid enhancing factor; Familial amyloidotic polyneuropathy; Genetic anticipation; Seed; Transgenic mouse model; Transthyretin

Indexed keywords

AMYLOID; APOLIPOPROTEIN A2; PREALBUMIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACTION; FEMALE; GENE EXPRESSION; HEART; HUMAN; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; ANIMALS; HUMANS; LIVER; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; MUTATION; MYOCARDIUM; PREALBUMIN;

EID: 20844445810     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.1080/13506120410001726344     Document Type: Article

References (32)

1. Xing Y and Higuchi K (2002). Amyloid fibril proteins. Mechanisms of Ageing and Development 123, 1625-1636
2. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione, B, Ikeda S, Masters CL, Merlini G, Saraiva MJ and Sipe JD (2002). Amyloid fibril protein nomenclature 2002. Amyloid. J Protein Folding Dis 9, 197-200
3. Kelly JW (2000). Mechanisms of amyloidogenesis. Nat Struct Biol 7, 824-826
4. Kelly JW (2002). Towards an understanding of amyloidogenesis. Nat Struct Biol 9, 323-325
5. Jarrett JT and Lansbury PTJr (1993). Seeding "one dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie. Cell 73, 1055-1058
6. Horwich AL and Weissman JS (1997). Deadly conformations-protein misfolding in prion disease. Cell 89, 499-510
7. Hasegawa K, Yamaguchi I, Omata S, Gejyo F and Naiki H (1999). Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro. Biochemistry 38, 15514-15521
8. Yamaguchi I, Hasegawa K, Naiki H, Mitsu T, Matuo Y and Gejyo F (2001). Extension of A beta2M amyloid fibrils with recombinant human beta2-microglobulin. Amyloid. J Protein Folding Dis 8, 30-40
9. Higuchi K, Hosokawa M and Takeda T (1999). Senescence-accelerated mouse. Methods Enzymol 309, 674-686
10. Johan K, Westermark G, Engstrom U, Gustavsson A, Hultman P and Westermark P (1998). Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 95, 2558-2563
11. Lundmark K, Westermark GT, Nystrom S, Murphy CL, Solomon A and Westermark P (2002). Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci USA 99, 6979-6984
12. Prusiner SB (1998). Prions. Proc Natl Acad Sci USA 95, 13363-13383
13. Xing Y, Nakamura A, Chiba T, Kogishi K, Matsushita T, Li F, Guo Z, Hosokawa M, Mori M and Higuchi K (2001). Transmission of mouse senile amyloidosis. Lab Invest 81, 493-499
14. Sigurdsson E, Wisniewski T and Frangione B (2002). Infectivity of amyloid diseases. Trends Mol Med 8, 411-413
15. Hamilton JA and Benson MD (2001). Transthyretin: a review from a structural perspective. Cell Mol Life Sci 58, 1491-1521
16. Benson MD and Cohen AS (1977). Generalized amyloid in a family of Swedish origin: A study of 426 family members in seven generations of a new kinship with neuropathy, nephropathy, and central nervous system involvement. Ann Intern Med 86, 419-424
17. Soares M, Buxbaum J, Sirugo G, Coelho T, Sousa A, Kastner D and Saraiva MJ (1999). Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions. Hum Genet 104, 480-485
18. Drugge U, Andersson R, Chizari F, Danielsson M, Holmgren G, Sandgren O and Sousa A (1993). Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. J Med Genet 30, 388-392
19. Tashima K, Ando Y, Tanaka Y, Uchino M and Ando M (1995). Change in the age of onset in patients with familial amyloidotic polyneuropathy type I. Intern Med 34, 703-704
20. Kohno K, Palha JA, Miyakawa K, Saraiva MJM, Ito S, Mabuchi T, Blaner WS, Iijima H, Tsukahara S, Episkopou V, Gottesman ME, Shimada K, Takahashi K, Yamamura K and Maeda S (1997). Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy. Am J Pathol 150, 1497-1508
21. Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME and Robertson EJ (1993). Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA 90, 2375-2379
22. Pras M, Schubert M, Zucker-Franklin D, Rimon A and Franklin EC (1968). The characterization of soluble amyloid prepared in water. J Clin Invest 47, 924-933
23. Higuchi K, Kogishi K, Wang J, Chen X, Chiba T, Matsushita T, Hoshii Y, Kawano H, Ishihara T, Yokota T and Hosokawa M (1998). Fibrilization in mouse senile amyloidosis is fibril conformation-dependent. Lab Invest 78, 1535-1542
24. Naiki H, Higuchi K, Hosokawa M and Takeda T (1989). Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem 177, 244-249
25. Xing Y, Nakamura A, Korenaga T, Guo Z, Yao J, Fu X, Matsushita T, Kogishi K, Hosokawa M, Kametani F, Mori M and Higuchi K (2002). Induction of protein conformational change in mouse senile amyloidosis. J Biol Chem 277, 33164-33169
26. Schagger H and Jagow G (1987). Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166, 368-379
27. Hoshii Y, Kawano H, Gondo T, Takahashi M, Ishihara T, Higuchi K and Horiuchi S (1986). Immunohistochemical study with anti-advanced glycation end-products antibody in murine amyloidosis. Pathol Int 46, 738-742
28. Higuchi K, Matsumura A, Honma A, Takeshita S, Hashimoto K, Hosokawa M, Yasuhira K and Takeda T (1983). Systemic senile amyloid in senescence- accelerated mice: A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab Invest 48, 231-240
29. Noguchi H, Ohta M, Wakasugi S, Noguchi K, Nakamura N, Nakamura O, Miyakawa K, Takeya M, Suzuki M, Nakagata N, Urano T, Ono T and Yamamura K (2002). Effect of the intestinal flora on amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy. Exp Anim 51, 309-316
30. Mambule C, Ando Y, Anan I, Holmgren G, Sandgren O, Stigbrand T, Tashima K and Suhr OB (2000). Enhancement of AA-amyloid formation in mice by transthyretin amyloid fragments and polyethylene glycol. Biochimica et Biophysica Acta 1474, 331-336
31. Teng MH, Yin JY, Vidal R, Ghiso J, Kumar A, Rabenou R, Shah A, Jacobson DR, Tagoe C, Gallo G and Buxbaum J (2001). Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis. Lab Invest 81, 385-396
32. Hammarstrom P, Wiseman RL, Powers ET and Kelly JW (2003). Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 299, 713-716